Ligand Pharmaceuticals
LGND
#4061
Rank
A$3.56 B
Marketcap
$188.43
Share price
1.11%
Change (1 day)
117.94%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.36

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.42. In 2022 the company made an earnings per share (EPS) of -$3.06 a decrease over its 2021 EPS that were of $5.34.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-177.26%
2022-$3.06-157.23%
2021$5.34-2571.43%
2020-$0.22-100.46%
2019$47.25353.48%
2018$10.421025%
2017$0.93-700%
2016-$0.15-100.87%
2015$17.841859.32%
2014$0.915.36%
2013$0.868.0704505322479E+18%
2012$0.0000000000-100%
2011$0.76-194.23%
2010-$0.80548.38%
2009-$0.12-98.7%
2008-$9.54-136.52%
2007$26.12-787.8%
2006-$3.80-14.58%
2005-$4.45-21.31%
2004-$5.65-55.15%
2003-$12.5981.33%
2002-$6.952.74%
2001-$6.76-45.93%
2000-$12.50-14.56%
1999-$14.63-45.52%
1998-$26.86-3.97%
1997-$27.97132.31%
1996-$12.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.84 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.56-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.40 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.81 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.87 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.38 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.13 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.90 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.74 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA